Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 3, 2009, Pages 836-845

  Rubner, Paul ^a   Koppi, Stefan ^a   Conca, Andreas ^b  

^a Departments of Neurology   (Austria)

^b Regional Hospital of Rankweil   (Austria)

Author keywords

Antiepileptic drugs; Bipolar affective disorder; ECT; Mood stabilizers

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OXCARBAZEPINE; TIOTIXENE; VALPROIC ACID; DRUG DERIVATIVE; LITHIUM CARBONATE; TRIAZINE DERIVATIVE;

AUSTRIA; BIPOLAR DISORDER; ELECTROCONVULSIVE THERAPY; EPILEPSY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; REVIEW; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; STATISTICS; TREATMENT OUTCOME;

ANTICONVULSANTS; AUSTRIA; BIPOLAR DISORDER; CARBAMAZEPINE; COMBINED MODALITY THERAPY; ELECTROCONVULSIVE THERAPY; GUIDELINES AS TOPIC; HUMANS; LITHIUM CARBONATE; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 77949496410     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970902838242     Document Type: Review

References (113)

1. Aarre TF, Bugge P. 2002. ECT for patients taking lamotrigine. Eur Psychiatry 17(Suppl 1):135.
2. Abrams R, Volavka J, Schrift M. 1992. Brief pulse ECT in melancholia. EEG and clinical effects. J Nerv Ment Dis 180:555-557.
3. Adli M, Bschor T, Canata B, Dopfmer S, Bauer M. 1998. Lithium in the treatment of acute depression. Fortschr Neurol Psychiatr 66:435-441.
4. American Psychiatric Association. 2001. The practice of ECT: Recommendations for treatment, training and privileging. 2nd ed. Washington, DC: American Psychiatric Publishers.
5. Andersen FA, Arsland D, Holst-Larsen H. 2001. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 45:830-833.
6. Avramov MN, Husain MM, White PF. 1995. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 81:596-602.
7. Bachmann RF, Schloesser RJ, Gould TD, Manji HK. 2005. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 32:173-202.
8. Barbee JG, Jamhour NJ. 2002. Lamotrigine as an augmentation agent in treatment-resistant depression. J Clin Psychiatry 63:737-741.
9. Barbosa L, Berk M, Vorster M. 2003. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiatry 64:403-407
10. Basselin M, Chang L, Rapoport SI. 2006. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation. Psycho-pharmacology 187:303-311.
11. Bhat SK, Acosta D, Swartz CM. 2002. Postictal asystole during ECT. J ECT 18:103-106.
12. Black DW, Winokur G, Nasrallah A. 1987. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 48:132-139.
13. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, et al. 2006. Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. Eur Neuropsy-chopharmacol 16:620-624. (Pubitemid 44781079)
14. Bourgon LN, Kellner CH. 2000. Relapse of depression after ECT: a review. J ECT 16:19-31.
15. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. 1994. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J Am Med Assoc 271:918-924.
16. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. 2000. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57:481-489
17. Bowden CL, Calabrese JR, Sachs G, Lakshmi N, Yatham LN, Asghar SA, et al. Lamictal 606 Study Group. 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392-400 (Pubitemid 36403000)
18. Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, et al. 2006. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 67:1025-1033. (Pubitemid 44230872)
19. Bromet EJ, Finch SJ, Carlson GA, Fochtmann L, Mojtabai R, Craig TJ, et al. 2005. Time to remission and relapse after the first hospital admission in severe bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 40:106-113.
20. Cantor C. 1986. Carbamazepine and ECT: a paradoxical combination. J Clin Psychiatry 47:276-277.
21. Challiol V. 1940. L?azione del luminal nella crisi dell'elet-troschock. Riv Sper Freniat Med Legale 664:635-648.
22. Craig TJ, Grossman S, Mojtabai R, Gibson PJ, Lavelle J, Carlson GA, et al. 2004. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features. Bipolar Disord 6:406-415.
23. Devanand DP, Sackeim HA, Decina P, Prudic J. 1988. The development of mania and organic euphoria during ECT. J Clin Psychiatry 49:69-71.
24. Di Daniel E, Cheng L, Maycox PR, Mudge AW. 2006. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol Cell Neurosci 32:27-36.
25. Dixon JF, Hokin LE. 1998. Lithium acutely inhibits and chronically upregulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 95:8363-8368.
26. Dolenc TJ, Rasmussen KG. 2005. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT 21:165-170.
27. Fink M. 2001. Convulsive therapy: a review of the first 55 years. J Affect Disord 63:1-15.
28. Frederikse M, Petrides G, Kellner C. 2006. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report. J ECT 22:13-17.
29. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. 1992. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149:108-111.
30. Gagne GG, Furman MJ, Carpenter LL, Price LH. 2000. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157:1960-1965.
31. Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH. 1996. Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia 37:515-521.
32. Geddes J. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799-808.
33. Gelenberg AJ, Pies R. 2003. Matching the bipolar patient and the mood stabilizer. Ann Clin Psychiatry 15:203-216.
34. Gitlin M. 2006. Treatment-resistant bipolar disorder. Mol Psychiatry 11:227-240.
35. Goldberg JF, Harrow M. 2004. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord 81:123-131.
36. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, et al. 2004. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432-441.
37. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391-426
38. Grunhaus L, Dolberg O, Lustig M. 1995. Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiatr Res 29:165-172.
39. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, et al. 2002. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 3:115-124.
40. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, et al. 2003. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of mania. World J Biol Psychiatry 4:5-13.
41. Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ. 2004. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 5:120-135.
42. Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME. 2002. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus. Brain Res 952:52-60. (Pubitemid 35279487)
43. Hantouche EG, Akiskal HS, Lancrenon S, Chatenet-Duchene L. 2005. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. J Affect Disord 84:243-249.
44. Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA; LitCar Group. 2003. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 64:144-151.
45. Holt WL Jr, Borkowski W 1951. Drug-modified electric shock therapy; clinical response to partial seizures facilitated by the anticonvulsant drugs, diphenylhydantoin and mephenesin, alone and in combination. Psychiatr Q 25:581-588.
46. Ishihara K, Sasa M. 1999. Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. Jpn J Pharmacol 80:185-189.
47. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher Pl. 1985. Efficacy of ECT: a meta-analysis. Am J Psychiatry 142:297-302.
48. Joo EY, Hong SB, Tae WS, Han SJ, Seo DW, Lee KH, et al. 2006. Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy. Eur J Nucl Med Mol Imaging 33:724-729.
49. Joseph TC, Ronald SD. 2003. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157-160.
50. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. 2002. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59:530-537.
51. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, et al. 2003. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60:261-269.
52. Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R. 2000. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J Psychiatr Pract 6:197-211.
53. Kalin NH. 1996-1997. Management of the depressive component of bipolar disorder. Depress Anxiety 4:190-198.
54. Kaufman KR, Finstead BA, Kaufman ER. 1986. Status epilepti-cus following electroconvulsive therapy. Mt Sinai J Med 53:119-122.
55. Kellner CH. 1999. ECTand manic switching: bipolar IV disorder. J ECT 15:243-244.
56. Khalid N, Atkins M, Kirov G. 2006. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 22:184-188.
57. Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. 2003. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 19:139-147.
58. Klapheke MM. 1991. Clozapine, ECT, and schizoaffective disorder, bipolar type. Convuls Ther 7:36-39.
59. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7(Suppl 1):S71-80.
60. Landmark CJ. 2007. Targets for antiepileptic drugs in the synapse. Med Sci Monit 13:1-7.
61. Layne EM, Young JL, Votolato NA, Nicholas A, Miller KM, Martin BS. 2005. Effect of concurrent lamotrigine in patients receiving electroconvulsive therapy. J ECT 21:60.
62. Leiderman DB, Balish M, Bromfield EB, Theodore WH. 1991. Effect of valproate on human cerebral glucose metabolism. Epilepsia 32:417-422
63. Li X, Bijur GN, Jope RS. 2002. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 4: 137-144.
64. Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M. 2001. Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 3:165-173.
65. Lunde ME, Lee EK, Rasmussen KG. 2006. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav 9:355-359.
66. Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM. 2001. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 3:CD003196.
67. Macritchie KA, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. 2003. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 1:CD004052.
68. Mai L, Jope RS, Li X. 2002. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82:75-83.
69. Manning JS, Haykal RF, Connor PD, Cunningham PD, Jackson WC, Long S. 2005. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament. J Affect Disord 84:259-266.
70. Marchetti RL, Fiore LA, Peluso MA, Rigonatti SP. 2003. Safety and efficacy of ECT in mental disorders associated with epilepsy: report of three cases. J ECT 19:173-176.
71. McCall WV, Reboussin DM, Weiner RD, Sackeim HA. 2000. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 57:438-444.
72. Mukherjee S. 1993. Combined ECTand lithium therapy. Convuls Ther 9:274-284.
73. Mukherjee S, Sackeim HA, Schnur DB. 1994. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 151:169-176.
74. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, et al. 2001. Decreased regional brain metabolism after ECT. Am J Psychiatry 158:305-308.
75. Patel AS, Gorst-Unsworth C, Venn RM, Kelley K, Jacob Y. 2006. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol. J ECT 22:179-183.
76. Pearlman C, Obedian E. 1995. ECT-valproic acid interaction. Gen Hosp Psychiatry 17:456-457
77. Penland HR, Ostroff RB. 2006. Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series. J ECT 22:142-147.
78. Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA. 2004. Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology 29:813-825.
79. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, et al. 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 17:244-253.
80. Plattner P. 1949. Die chirurgischen Komplikationen bei der Elektroschockbehandlung und ihre Vermeidung durch Mesan-toin. Monatsschr Psychiatr Neurol 188:192-227.
81. Post RM. 2007. Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. J Psychiatr Res 41: 979-990.
82. Post RM, Putman F, Contel NR, Goldman B. 1984. Electroconvulsive seizure inhibit amygdala kindling: implications for mechanisms of action in affective illness. Epilepsia 25:234-239.
83. Post RM, Putnam F, Uhde TW, Weiss SR. 1986. Electroconvulsive therapy as an anticonvulsant: implication for its mechanism of action in affective illness. Ann NY Acad Sci 462:376-388.
84. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. 1996. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153:985-992.
85. Pratoomsri W, Yatham LN, Bond DJ, Lam RW, Sohn CH. 2006. Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry 51:540-545.
86. Rabheru K, Persad E. 1997. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry 42:476-484
87. Roberts MA, Attah JR. 1988. Carbamazepine and ECT. Br J Psychiatry 153:418.
88. Roh MS, Kang UG, Shin SY, Lee YH, Jung HY, Juhnn YS, et al. 2003. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 27:1-5.
89. Russell JC, Rasmussen KG, O'Connor MK, Copeman CA, Ryan DA, Rummans TA. 2003. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT 19:4-9.
90. Sackeim HA. 1999. The anticonvulsive hypothesis of mechanism of action of ECT: current status. J ECT 15:25-26.
91. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. 2000. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57:425-434
92. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, et al. 2003. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160:577-579.
93. Sartorius A, Wolf J, Henn FA. 2005. Lithium and ECT-concurrent use still demands attention: three case reports. World J Biol Psychiatry 6:121-124.
94. Schaffer A, Zuker P, Levitt A. 2006. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 96:95-99.
95. Sienaert P, Peusken J. 2007. Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT 23:120-123.
96. Sienaert P, Bouckaert F, Hagon A, Hagon B, Peusken J. 2004. Short seizure in continuation electroconvulsive therapy: an indication for remifentanil anesthesia? J ECT 20:130-131.
97. Sienaert P, Demunter H, Vansteelandt K. 2006. Effect of lamotrigine on concurrent electroconvulsive therapy. Eur Neuropsychopharmacol 16(Suppl 4):348.
98. Sikdar S, Kulhara P, Avasthi A, Singh H. 1994. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry 164:806-810.
99. Small JG. 1990. Anticonvulsants in affective disorders. Psycho-pharmacol Bul 26:25-36.
100. Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, et al. 1988. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 45:727-732
101. Southam E, Kirkby D, Higgins GA, Hagan RM. 1998. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 358:19-24.
102. Stewart JT 2000. Lithium and maintenance ECT. J ECT 16: 300-301.
103. Strome EM, Clark CM, Zis AP, Doudet DJ. 2005. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhu-man primates: an in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 57:1004-1010.
104. Swoboda E, Conca A, Konig P, Waanders R, Hansen M. 2001. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43:23-28.
105. Thornton JE, Mulsant BH, Dealy R, Reynolds CF 3rd. 1990. A retrospective study of maintenance electroconvulsive therapy in a university-based psychiatric practice. Convuls Ther 6: 121-129.
106. Vaidya NA, Mahableshwarkar AR, Shahid R. 2003. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT 19:10-16.
107. Van den Broeck WW, Huyser J, Koster AM. 2000. Richtlijn elektroconvulsiv therapie. Amsterdam: Boom.
108. Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, et al. 1994. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 10:195-205.
109. Vishne T, Aronov S, Amiaz R, Etchin A, Grunhaus L. 2005. Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT 21:235-238.
110. Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, et al. 2006. SPD417 Study Group. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 20:219-231.
111. Winsberg ME, DeGolia SG, Strong CM, Ketter TA. 2001. Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. J Affect Disord 67:207-212.
112. Zarate CA Jr, Tohen M, Baraibar G. 1997. Combined valproate or carbamacepine and electroconvulsive therapy. Ann Clin Psychiatry 9:19-25.
113. Zwil AS, Pomerantz A. 1997. Transient postictal psychosis associated with a course of ECT. Convuls Ther 13:32-36.